Cyklokapron Alternatives Compared
| Cyklokapron (tranexamic acid) | Tranexamic acid | Zoladex (goserelin) |
|
|---|
| Cyklokapron (tranexamic acid) | Tranexamic acid | Zoladex (goserelin) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Bleeding Disorder, Hemophilia A, Factor IX Deficiency. Cyklokapron may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Heavy Menstrual Bleeding, Melasma, Bleeding Disorder, Menstrual Disorders, Hemophilia A, Factor IX Deficiency. Tranexamic acid may also be used for purposes not listed in this medication guide. View more |
Prescription only
Prescribed for Prostate Cancer, Breast Cancer - Palliative, Endometriosis, Bleeding Disorder. Zoladex may also be used for purposes not listed in this medication guide. |
Related suggestions Bleeding Disorder
Popular comparisons
|
|||||||||||||||||||||||
| More about Cyklokapron (tranexamic acid) | More about Tranexamic acid | More about Zoladex (goserelin) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Cyklokapron has an average rating of 6.8 out of 10 from a total of 8 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 38% reported a negative effect. |
Tranexamic acid has an average rating of 6.9 out of 10 from a total of 278 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 23% reported a negative effect. |
Zoladex has an average rating of 6.6 out of 10 from a total of 103 ratings on Drugs.com. 52% of reviewers reported a positive effect, while 21% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Cyklokapron side effects |
View all Tranexamic acid side effects |
View all Zoladex side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Cyklokapron prices |
View all Tranexamic acid prices |
View all Zoladex prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other tranexamic acid brands include: Lysteda | Cyklokapron, Lysteda | Other goserelin brands include: Zoladex 3-Month | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
2 hours |
2 hours |
4.2 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 61 drugs are known to interact with Cyklokapron:
|
A total of 61 drugs are known to interact with Tranexamic acid:
|
A total of 284 drugs are known to interact with Zoladex:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
N/A |
April 15, 2019 |
December 29, 1989 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
|||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.